![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print May 10, 2001
MRC CMU, University of Sussex, Brighton BN1 9RR
Corresponding Author: b.kysela{at}sussex.ac.uk
DNA ligase IV functions in DNA non-homologous end-joining, V(D)J recombination and during brain development. We previously reported a homozygous mutation (R278H) in DNA ligase IV in a developmentally normal leukaemia patient who overresponded to radiotherapy. The impact of this hypomorphic mutation has been evaluated using cellular, biochemical and structural approaches. Structural modelling using T7 DNA ligase predicts that the activity and conformational stability of the protein is likely to be impaired. We show that wild type DNA ligase IV/Xrcc4 is an efficient double-stranded ligase with distinct optimal requirements for adenylate complex formation versus rejoining. The mutation impairs the formation of an adenylate complex as well as reducing the rejoining activity. Additionally, it imparts temperature-sensitive activity to the protein consistent with the predictions of the structural modelling. At the cellular level, the mutation confers a unique V(D)J recombination phenotype affecting the fidelity of signal join formation with little effect on the frequency of the reaction. These findings suggest that hypomorphic mutations in ligase IV may allow normal development and but confer marked radiosensitivity.
J. Biol. Chem, 10.1074/jbc.M103866200
Submitted on April 30, 2001
Revised on May 10, 2001
Accepted on May 9, 2001
Cellular and biochemical impact of a mutation in DNA ligase IV conferring clinical radiosensitivity
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Liang, L. Deng, S. C. Nguyen, X. Zhao, C. D. Maulion, C. Shao, and J. A. Tischfield Human DNA ligases I and III, but not ligase IV, are required for microhomology-mediated end joining of DNA double-strand breaks Nucleic Acids Res., June 1, 2008; 36(10): 3297 - 3310. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Enders, P. Fisch, K. Schwarz, U. Duffner, U. Pannicke, E. Nikolopoulos, A. Peters, M. Orlowska-Volk, D. Schindler, W. Friedrich, et al. A Severe Form of Human Combined Immunodeficiency Due to Mutations in DNA Ligase IV. J. Immunol., April 15, 2006; 176(8): 5060 - 5068. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Damaraju, D. Murray, J. Dufour, D. Carandang, S. Myrehaug, G. Fallone, C. Field, R. Greiner, J. Hanson, C. E. Cass, et al. Association of DNA Repair and Steroid Metabolism Gene Polymorphisms with Clinical Late Toxicity in Patients Treated with Conformal Radiotherapy for Prostate Cancer Clin. Cancer Res., April 15, 2006; 12(8): 2545 - 2554. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, B. Rosidi, R. Perrault, M. Wang, L. Zhang, F. Windhofer, and G. Iliakis DNA Ligase III as a Candidate Component of Backup Pathways of Nonhomologous End Joining Cancer Res., May 15, 2005; 65(10): 4020 - 4030. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-M. Girard, B. Kysela, C. J. Harer, A. J. Doherty, and P. A. Jeggo Analysis of DNA ligase IV mutations found in LIG4 syndrome patients: the impact of two linked polymorphisms Hum. Mol. Genet., October 1, 2004; 13(20): 2369 - 2376. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kuhne, E. Riballo, N. Rief, K. Rothkamm, P. A. Jeggo, and M. Lobrich A Double-Strand Break Repair Defect in ATM-Deficient Cells Contributes to Radiosensitivity Cancer Res., January 15, 2004; 64(2): 500 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iwabuchi, B. P. Basu, B. Kysela, T. Kurihara, M. Shibata, D. Guan, Y. Cao, T. Hamada, K. Imamura, P. A. Jeggo, et al. Potential Role for 53BP1 in DNA End-joining Repair through Direct Interaction with DNA J. Biol. Chem., September 19, 2003; 278(38): 36487 - 36495. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kysela, A. J. Doherty, M. Chovanec, T. Stiff, S. M. Ameer-Beg, B. Vojnovic, P.-M. Girard, and P. A. Jeggo Ku Stimulation of DNA Ligase IV-dependent Ligation Requires Inward Movement along the DNA Molecule J. Biol. Chem., June 13, 2003; 278(25): 22466 - 22474. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Smith, E. Riballo, B. Kysela, C. Baldeyron, K. Manolis, C. Masson, M. R. Lieber, D. Papadopoulo, and P. Jeggo Impact of DNA ligase IV on the fidelity of end joining in human cells Nucleic Acids Res., April 15, 2003; 31(8): 2157 - 2167. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Dai, B. Kysela, L. A. Hanakahi, K. Manolis, E. Riballo, M. Stumm, T. O. Harville, S. C. West, M. A. Oettinger, and P. A. Jeggo Nonhomologous end joining and V(D)J recombination require an additional factor PNAS, March 4, 2003; 100(5): 2462 - 2467. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rief and M. Lobrich Efficient Rejoining of Radiation-induced DNA Double-strand Breaks in Centromeric DNA of Human Cells J. Biol. Chem., May 31, 2002; 277(23): 20572 - 20582. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Jackson Sensing and repairing DNA double-strand breaks Carcinogenesis, May 1, 2002; 23(5): 687 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Arosio, S. Cui, C. Ortega, M. Chovanec, S. Di Marco, G. Baldini, A. Falaschi, and A. Vindigni Studies on the Mode of Ku Interaction with DNA J. Biol. Chem., March 15, 2002; 277(12): 9741 - 9748. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, C. Nelsen, and E. A. Hendrickson Ku86 is essential in human somatic cells PNAS, January 22, 2002; 99(2): 832 - 837. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |